In this Exclusive Interview, Sylvia Ley talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about the concerns of eating processed red meat, especially for people at risk for developing diabetes.
Read More »Sylvia Ley Part 1, Red Meats and Diabetes
In part 1 of this Exclusive Interview, Sylvia Ley talks with Diabetes in Control Publisher Steve Freed about the difference between red meat and processed red meat, and the implications for consuming either.
Read More »Sylvia Ley Part 2, BBQ’d Meats and Carcinogens
In part 2 of this Exclusive Interview, Sylvia Ley talks with Diabetes in Control Publisher Steve Freed about the impact of using high heat when cooking meat and the cancer implications.
Read More »Sylvia Ley Part 3, What Should Be Taken From Your Presentation?
In part 3 of this Exclusive Interview, Sylvia Ley talks with Diabetes in Control Publisher Steve Freed about her overall message of a balanced, all-encompassing diet for people with diabetes, as recommended by medical experts.
Read More »Sylvia Ley Part 4, What Should People with Diabetes Eat?
In part 4, the conclusion of this Exclusive Interview, Sylvia Ley talks with Diabetes in Control Publisher Steve Freed about alternative proteins that are healthier options for people with diabetes.
Read More »Childhood Diabetes Lowers Lifespan by 18 Years
Researchers suggest implementation of cardioprotective medications sooner than current guideline recommendations.
Read More »Dapagliflozin Use in Managing Type 1 Diabetes
Adding an SGLT2 inhibitor helps lower HbA1c and decrease variability in glucose ranges among people with type 1 diabetes.
Read More »Comparison of Semaglutide versus Liraglutide for Weight Loss in Patients with Obesity
Researchers study efficacy and safety of GLP-1 inhibitors on weight loss.
Read More »Safety and Efficacy of Lorcaserin
New study focuses on cardiovascular safety of weight loss drug in patients with excess weight or obesity.
Read More »Biomarkers to Predict Cardiovascular Events in People with Type 2 Diabetes
The SUMMIT VIP study shows conventional risk factors do not suffice in predicting heart complications.
Read More »